- Christenson LJ, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005; 294:681-690.
- Rowert-Huber J, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156(Suppl.3):8-12.
- Wolf JE, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40:709-713.
- Smith SR, et al. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol 2006; 5:156-9.
- Li VW, et al. Imiquimod as an antiangiogenic agent. J Drugs Dermatol 2005; 4(6):708-717.
- Zand S, Li WW, Li VW. iMTD: An Algorithm-based Approach to Optimize Dose-Response in the Treatment of Skin Cancer Using Imiquimod. J Am Acad Dermatol 2004; 50(3):P129.
- Cuevas P, Arrazola JM. Therapeutic response of rosacea to dobesilate. Eur J Med Res 2005; 10:454-456.
- Cuevas P. Treatment of basal cell carcinoma with dobesilate. J Am Acad Dermatol 2005; 53(3):526-527.
- Fassina G, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res 2004; 10:4865-4873.
- Li V W, Li WW. Antiangiogenesis in the treatment of skin cancer. Journal of Drugs and Dermatology 2008; 6(11).
- Casanova ML, et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 2003; 111:43-50.
- Campistol JM, et al. Use of proliferation signal inhibitors in the management of post-transplant malignancies—clinical guidance. Nephrol Dial Transplant 2007; 22(Suppl 1):i36-i41.
- Loutari H, et al. Perillyl alcohol is an angiogenesis inhibitor. J Pharmacol Exp Therap 2004; 311(2):568-575.
- Arbiser JL, et al. Solenopsin, the alkaloidal component of the fire ant (solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis. Blood 2007; 109:560-565.
References